Skip to main content

Diabetes Screening for People With Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

CBE ID
1932
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
Next Planned Maintenance Review
Behavioral Health and Substance Use Spring 2025
1.3 Measure Description

The percentage of patients 18 – 64 years of age with schizophrenia or bipolar disorder, who were dispensed an antipsychotic medication and had a diabetes screening test during the measurement year.

        • 1.14 Numerator

          Among patients 18-64 years old with schizophrenia or bipolar disorder, those who were dispensed an antipsychotic medication and had a diabetes screening testing during the measurement year.

        • 1.15 Denominator

          Patients ages 18 to 64 years of age as of the end of the measurement year (e.g., December 31) with a schizophrenia or bipolar disorder diagnosis and who were prescribed an antipsychotic medication.

        • Exclusions

          Exclude members who use hospice services or elect to use a hospice benefit any time during the measurement year, regardless of when the services began.

          Exclude patients with diabetes during the measurement year or the year prior to the measurement year.

          Exclude patients who had no antipsychotic medications dispensed during the measurement year.

        • Most Recent Endorsement Activity
          Endorsed Behavioral Health and Substance Use Spring Cycle 2018
          Initial Endorsement
          Last Updated
        • Steward Organization Email
          Steward Organization Copyright

          The performance measures and specifications were developed by and are owned by the National Committee for Quality Assurance (“NCQA”). The performance measures and specifications are not clinical guidelines and do not establish a standard of medical care. NCQA makes no representations, warranties, or endorsement about the quality of any organization or physician that uses or reports performance measures and NCQA has no liability to anyone who relies on such measures or specifications. NCQA holds a copyright in these materials and can rescind or alter these materials at any time. These materials may not be modified by anyone other than NCQA. Anyone desiring to use or reproduce the materials without modification for an internal, quality improvement non-commercial purpose may do so without obtaining any approval from NCQA. All other uses, including a commercial use and/or external reproduction, distribution and publication must be approved by NCQA and are subject to a license at the discretion of NCQA.
          ©2018 NCQA, all rights reserved.
          Limited proprietary coding is contained in the measure specifications for convenience. Users of the proprietary code sets should obtain all necessary licenses from the owners of these code sets. NCQA disclaims all liability for use or accuracy of any coding contained in the specifications.
          Content reproduced with permission from HEDIS, Volume 2: Technical Specifications for Health Plans. To purchase copies of this publication, including the full measures and specifications, contact NCQA Customer Support at 888-275-7585 or visit www.ncqa.org/publications.